ChineseInvestors (CIIX) Expands CBD Sales in China


(NEW YORK)–, Inc. (OTCQB: CIIX) announced that its wholly owned division CBD Biotechnology Co. Ltd. has launched a two-tier, direct selling initiative to expand its CBD sales into China.

Best Trader Tool Around

As the President of the CBD Community Center, Mr. Xie will spearhead growing customer awareness of CBD Biotech’s inaugural line of hemp-infused skin care products, CBD Magic Hemp Series and its luxury line, Live Oxygen. In addition, he will manage building a community-centered around a direct selling team through seminars and expos designed for both business-to-business and business-to-customer sales opportunities. Members of the CBD Community Center will be compensated for product sales and will also receive stock-based performance bonuses. “We believe we are building the first Chinese CBD marketing community that offers our members the opportunity to become invested in the Company.

The CBD Community Center is located at Floor 27, A Unit, Industrial Investment Building, NO.18 North Caoxi Road, Shanghai, China.

CIIX recent move up comes on heels of stunning run in another CBD player called CV Sciences, Inc. (OTCMKTS:CVSI). CVSI has seen its stock rise from around $0.50 in XXX to a closing high just above $7.00 in recent trading.

CVSI recently reported Q2 revenue were expected to be $12.3 million, up 203% compared to the second quarter of 2017, and a 53% sequential increase over Q1 2018. In addition, the Company increased retail store count to 1,968 natural and organic health food stores as of June 30, 2018, representing an 11.1% sequential increase over the Company’s retail store count for the first quarter of 2018.

CVSI is showing some impressive execution on their business model, and shareholders are being rewarded nicely for this. But this also indicates increased interest in CBD players as potential for Democrats to take over the House in Congress this autumn could open the door for cannabis friendly bills coming to floor for vote. So strap in folks cause this mega rally within the CBD and cannabis sector may only just be starting.

About ChineseInvestors

Founded in 1999, endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online and direct sales of hemp-based products and other health related products. For more information visit

This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was compensated thirty thousand restricted shares by company for ongoing media services. WSNC, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.

Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.

High Risk
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial advisor before making any and all investment decisions when investing in these type of securities.